These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3044565)

  • 21. Psychopharmacologic approaches to borderline syndromes.
    Ellison JM; Adler DA
    Compr Psychiatry; 1984; 25(3):255-62. PubMed ID: 6145542
    [No Abstract]   [Full Text] [Related]  

  • 22. Psychopharmacological treatment of patients with borderline personality disorder: comparing data from routine clinical care with recommended guidelines.
    Riffer F; Farkas M; Streibl L; Kaiser E; Sprung M
    Int J Psychiatry Clin Pract; 2019 Sep; 23(3):178-188. PubMed ID: 31140337
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacological treatments for personality disorders.
    Paris J
    Int Rev Psychiatry; 2011 Jun; 23(3):303-9. PubMed ID: 21923229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychopharmacology of borderline personality disorder.
    Soloff PH
    Psychiatr Clin North Am; 2000 Mar; 23(1):169-92, ix. PubMed ID: 10729938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychopharmacology of borderline personality disorder: a review.
    Cowdry RW
    J Clin Psychiatry; 1987 Aug; 48 Suppl():15-25. PubMed ID: 2886493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology, risk factors, and psychopharmacological management of suicidal behavior in borderline personality disorder.
    Kolla NJ; Eisenberg H; Links PS
    Arch Suicide Res; 2008; 12(1):1-19. PubMed ID: 18240030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Borderline Personality Disorder and Oxytocin: Review of Clinical Trials and Future Directions.
    Amad A; Thomas P; Perez-Rodriguez MM
    Curr Pharm Des; 2015; 21(23):3311-6. PubMed ID: 26088114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The evidence that supports the effectiveness of certain psychopharmacologic agents and concern over the appropriate use of others.
    Flach F
    Essent Psychopharmacol; 2005; 6(6):vii-viii. PubMed ID: 16459753
    [No Abstract]   [Full Text] [Related]  

  • 29. The positive effect of alprazolam in the treatment of three patients with borderline personality disorder.
    Faltus FJ
    Am J Psychiatry; 1984 Jun; 141(6):802-3. PubMed ID: 6145360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacotherapy for patients with borderline personality disorder.
    Gunderson JG
    Arch Gen Psychiatry; 1986 Jul; 43(7):698-700. PubMed ID: 2872871
    [No Abstract]   [Full Text] [Related]  

  • 31. Recent advances in the treatment of borderline personality disorder.
    Paris J
    Can J Psychiatry; 2005 Jul; 50(8):435-41. PubMed ID: 16127960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for the treatment of borderline personality disorder.
    Gagliardi JP; Krishnan RR
    Psychopharmacol Bull; 2003; 37(1):30-46. PubMed ID: 14561947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological treatment of borderline personality disorder: a retrospective observational study at inpatient unit in Italy.
    Paolini E; Mezzetti FA; Pierri F; Moretti P
    Int J Psychiatry Clin Pract; 2017 Mar; 21(1):75-79. PubMed ID: 27669762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacotherapy for patients with borderline personality disorder.
    Goldberg SC; Schulz SC
    Arch Gen Psychiatry; 1988 Feb; 45(2):195-6. PubMed ID: 2892479
    [No Abstract]   [Full Text] [Related]  

  • 35. The psychopharmacologic treatment of personality disorders.
    Klar H; Siever LJ
    Psychiatr Clin North Am; 1984 Dec; 7(4):791-801. PubMed ID: 6151648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medication utilization patterns and methods of suicidality in borderline personality disorder.
    Makela EH; Moeller KE; Fullen JE; Gunel E
    Ann Pharmacother; 2006 Jan; 40(1):49-52. PubMed ID: 16303987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacotherapy of patients with borderline personality disorder.
    Teicher MH; Glod CA
    Hosp Community Psychiatry; 1989 Sep; 40(9):887-9. PubMed ID: 2676822
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical trials of treatment for personality disorders.
    Paris J
    Psychiatr Clin North Am; 2008 Sep; 31(3):517-26, viii. PubMed ID: 18638650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of melancholia during carbamazepine treatment in borderline personality disorder.
    Gardner DL; Cowdry RW
    J Clin Psychopharmacol; 1986 Aug; 6(4):236-9. PubMed ID: 3525615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug therapy in borderline patients.
    Cole JO; Salomon M; Gunderson J; Sunderland P; Simmonds P
    Compr Psychiatry; 1984; 25(3):249-54. PubMed ID: 6145541
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.